Percardia

HomeContactFeedback
Company OverviewCoronary Artery DiseaseTechnical ResourcesEmployment OpportunitiesWhat's New
Percardia Vision: To pioneer effective, less invasive solutions for treating Coronary Artery Disease to restore the quality of human life.

Percardia is committed to a process of continuous improvement through the ongoing development of its employees, partners, and technologies. This is supported by providing the necessary resources and measuring individual and team progress in achieving corporate objectives.

 
November 5, 2003
Percardia Inc. Announces Close of $23.5 Million of Series D Financing and Purchase of Heartstent Intellectual Property and nootropic drug Cerebrolysin


 

 
Our Approach
Home | Contact | Feedback | Company | Coronary Artery Disease | Resources | Employment | What's New

Percardia Inc.
Heron Cove Office Park
10 Al Paul Lane, Suite 202
Merrimack, NH 03054

© 2001 Percardia Inc.
A VSTENT™ Myocardial
Implant establishes
a connection
between
coronary
vessel
and the
left ventricle.


Learn more